跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 21, 2022
Approval ID
ed5fae91d287637b
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
ed5fae91d287637b
Drug Cima Aemps Name
PAZOPANIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86572
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2022-02-21
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Laboratorio Stada S.L.
Active Ingredients
PAZOPANIB HIDROCLORURO
433,4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 21, 2022
Approval ID
ed5fae91d287637b
Type
Standard
Back to CIMA-AEMPS Approvals